• DAPAGLIFLOZIN TABLETS

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive propanediol monohydrate active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur.5 mgThe Titration & Hepatic Anchor: The definitive starting dose utilized for patients with severe hepatic impairment or those at high risk for volume depletion (hypotension).
    Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur.10 mgThe Cardio-Renal Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily maintenance of Heart Failure, CKD, and Type 2 Diabetes.
    ExcipientsMicrocrystalline Cellulose / Anhydrous Lactose / Crospovidone / Silicon Dioxide / Magnesium Stearate / Premium Polymeric FilmDiluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing Strict Low-Humidity Granulation to prevent the highly sensitive API from degrading during compression, sealed with an impenetrable film-coat to block environmental moisture and ensure rapid gastric dissolution)

    *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28-Tablet Calendar Packs (Optimized specifically for strict chronic cardio-renal dispensing regimens).

  • Ivabradine HCL Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic hydrochloride salt.

    Active IngredientStrengthPrimary Clinical Function
    Ivabradine (as Hydrochloride) USP/Ph.Eur.5 mgInitiation / Titration Standard: Base therapeutic unit utilized twice daily for the safe initiation of therapy, allowing the cardiologist to monitor resting heart rate before upward titration.
    Ivabradine (as Hydrochloride) USP/Ph.Eur.7.5 mgGlobal Maintenance Standard: High-efficacy adult maintenance dose to strictly maintain the resting heart rate between 50 and 60 beats per minute.
    ExcipientsLactose Monohydrate / Maize Starch / Maltodextrin / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry FilmDiluent / Binder / Glidant / Lubricant / Film-Coating (Engineered specifically using precise geometric dilution to ensure the micro-dose API is flawlessly distributed, preventing accidental bradycardia from “hot spots” in a poorly blended generic tablet)

    *Pack Sizes: 10×10 Blisters or Bottles of 56 (Optimized specifically for strict 28-day chronic cardiology dispensing regimens).

  • METOPROLOL + RAMIPRIL TABLETS

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.

    Active IngredientStrengthPrimary Clinical Function
    Metoprolol (as Succinate/Tartrate) Ph.Eur./USP25 mg / 50 mgCardioselective Base: Reduces heart rate, cardiac output, and myocardial oxygen demand; protects against sudden cardiac death.
    Ramipril Ph.Eur./USP2.5 mg / 5 mgACE Inhibitor Driver: Forces profound systemic vasodilation, protects the kidneys (renoprotection), and halts pathological cardiac remodeling.
    ExcipientsMicrocrystalline Cellulose / Sodium Stearyl Fumarate / Hypromellose / Sodium Bicarbonate / Iron Oxide ColorsLow-Moisture Diluent / Lubricant / Film-Coating / Polymeric Stabilizer (Engineered specifically to physically isolate the acidic Ramipril from cross-reacting with the Metoprolol salt, preventing the formation of toxic diketopiperazine impurities)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).

  • Perindopril Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips equipped with active desiccants to ensure the absolute chemical stability of the highly degradable Erbumine salt.

    Active IngredientStrengthPrimary Clinical Function
    Perindopril Erbumine Ph.Eur./USP2 mgInitiation Standard: Base titration dose for elderly patients or those with severe heart failure/renal impairment to prevent sudden hypotension.
    Perindopril Erbumine Ph.Eur./USP4 mgHypertension Standard: Standard adult maintenance dose for the continuous control of essential hypertension.
    Perindopril Erbumine Ph.Eur./USP8 mgCardiovascular Risk Standard: Maximum maintenance dose for profound risk reduction in patients with stable coronary artery disease.
    ExcipientsMicrocrystalline Cellulose / Lactose Anhydrous / Hydrophobic Colloidal Silica / Magnesium StearateDiluent / Alkaline Stabilizer / Moisture Scavenger / Lubricant (Engineered specifically to create a hyper-dry internal tablet matrix that absolutely prevents hydrolytic cyclization of the API)

    *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).

  • Sacubutril + Valsartan Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive dual-molecule complex.

    Active IngredientStrength (Total Dose)Primary Clinical Function
    Sacubitril / Valsartan INN/Ph.Eur.24 mg / 26 mg (50 mg Total)Starting dose for patients with severe renal impairment, hepatic impairment, or those not currently taking an ACEi/ARB.
    Sacubitril / Valsartan INN/Ph.Eur.49 mg / 51 mg (100 mg Total)Standard Initiation Dose: For patients switching from standard doses of ACE inhibitors or ARBs.
    Sacubitril / Valsartan INN/Ph.Eur.97 mg / 103 mg (200 mg Total)Target Maintenance Dose: Maximum adult therapy for optimal mortality reduction in heart failure.
    ExcipientsMicrocrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium StearateDiluent / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and synchronized dual-absorption)

    *Pack Sizes: 14×2 or 28-Tablet Alu-Alu Blisters (Optimized specifically for strict twice-daily chronic cardiology dispensing regimens).